Tag: Ipsen

Ipsen partnered with MD Anderson Cancer Center to develop new cancer drug

cancer treatment
Ipsen, a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate.

Arix Bioscience and Ipsen start cooperation on innovative therapies

Arix Bioscience, a global healthcare and life science company, and Ipsen, a global specialty-driven biopharmaceutical company announced a strategic agreement to develop and commercialise innovative therapies.